Kate Drake, Head of Product Marketing with Corindus, a Siemens Healthineers Company, discusses the CorPath® GRX robotic system that was developed to make complex heart and brain procedures safer for patients and physicians by limiting radiation exposure and making physician movements more precise, but it can also be operated remotely. Currently, physicians will control the robot while seated across the room, but a cardiologist in India successfully performed five heart procedures in 2018 while controlling the robot over a hardwired internet connection from 20 miles away. Robotic-assisted procedures are turning out to be very beneficial during the pandemic.
Kate Drake is an experienced marketing leader with nearly a decade specializing in medical robotics. In her role, she oversees the company’s marketing efforts and works directly with physicians interested in learning about the benefits of robotic-assisted procedures. Beginning with Corindus in the early stages of clinical trials, Kate has seen the company go through the commercialization of two generations of robotic technology, IPO, expansion to multiple markets globally including cardiovascular, peripheral vascular, and neurovascular, and most recently the $1.1B acquisition by Siemens Healthineers. In her tenure at Corindus, she has served in multiple functions including Finance, Administration, and various roles in Marketing. Kate holds a bachelor’s degree in International Relations from Boston University.